ARCHIVES

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

NCAB May Determine Fate Of NCOG, Possibly Other Regional Groups; Simone Denies CCIRC Prejudice

May 8, 1981

Longer Infusion More Effective For Pancreatic Cancer

September 26, 2003

Sanofi Responds to Criticism From Oncologists

November 8, 2012

NCAB Committee Close To Definition Of QRA

February 11, 1983

In Brief: AMA Issues Guidelines For HIV Infection, Smoking Cessation; MDA Appointment

February 4, 1994

Research vs. Delivery? Advisors Debate NCI Role In Review of Community Program.

November 21, 2008